Search
Menu
Home
HTB
2012
July
21
21 July 2012
Contents
Editorial
2012 pipeline report launched in Washington: HIV, HCV, TB, PEP, cure and vaccine research
Press release: 2012 pipeline report launched in Washington
HTB supplement: 2012 pipeline report
Pipeline report
Introduction and executive summary
The antiretroviral pipeline 2012
The pediatric antiretroviral pipeline
Retrofitting for purpose: treatment optimisation 2012
Preventive technologies, research toward a cure, and immune-based and gene therapies
Hepatitis C drug development goes from pony ride to rocket launch
Hepatitis C (HCV) treatment access: spotlight on Thailand/Asia
The tuberculosis diagnostics pipeline
The tuberculosis treatment pipeline
The tuberculosis vaccine pipeline
Acknowledgments
HTB RSS
Early access
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Why the new HIV PrEP guidelines from the UK are so exciting
2 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate